Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1998 Jul 20;188(2):233–245. doi: 10.1084/jem.188.2.233

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Effects of antiretroviral therapy on IgG-ASC frequencies and viral load. Longitudinal IgG-ASC and viral load data for (a) four acutely and (b) six chronically infected individuals from cohort 1. Antiviral therapy was initiated on day 0. Baseline ASC data were not available from subjects no. 909 and no. 896, so the first data points are from wk 1 and 3 after therapy was initiated, respectively. The half-lives of IgG-ASCs are indicated on the figures for nine of the individuals. Note that, unlike in Fig. 3, the IgG-ASC frequencies are plotted on different scales for each individual, in order to depict the rates of change of ASC frequency with maximum clarity.

Effects of antiretroviral therapy on IgG-ASC frequencies and viral load. Longitudinal IgG-ASC and viral load data for (a) four acutely and (b) six chronically infected individuals from cohort 1. Antiviral therapy was initiated on day 0. Baseline ASC data were not available from subjects no. 909 and no. 896, so the first data points are from wk 1 and 3 after therapy was initiated, respectively. The half-lives of IgG-ASCs are indicated on the figures for nine of the individuals. Note that, unlike in Fig. 3, the IgG-ASC frequencies are plotted on different scales for each individual, in order to depict the rates of change of ASC frequency with maximum clarity.